SUMMARY We studied 12 patients with ventricular parasystole in whom pacemaker activity could be modulated by nonparasystolic beats (NPBs). In six patients (group 1) in whom the intrinsic parasystolic cycle length (XX interval) was obtained without interposed NPBs, we found that NPBs falling during the first half of the cycle prolonged the XRX interval (containing one NPB) and that NPBs falling during the second half of the cycle abbreviated the XRX interval; both effects were maximal when NPBs fell close to the middle of the cycle and were separated by a reversal point. However, because of mutual interference between parasystolic beats and NPBs, only 13.2-43.4% of the parasystolic cycle could be effectively scanned. We also found that the XRX and RX intervals were linearly related. This relationship served to establish that in six patients in whom the XX interval was not obtained (group 2), modulation showed a similar behavior, although neither the reversal point nor the sense of the modulation could be determined. In this report, we suggest diagnostic criteria of parasystolic modulation.IN CLASSIC parasystole, an automatic focus is assumed to be totally independent of the electric activity elsewhere in the heart. Entrance block (a form of unidirectional block) is the barrier that protects the parasystolic center from exogenous influences. However, a mechanism by which nonparasystolic beats (NPBs) can modify the activity of a protected automatic center has been conceived by Jalife and Moe.I They reasoned that "if an impulse cannot invade the pacemaker, but the pacemaker impulses can escape, then clearly there must be a viable ionic pathway across the blocked region." Using an in vitro preparation -the sucrose gap model -they established the existence of an electrotonic action exerted, by evoked action potentials or current pulses, on the activity of a protected pacemak-
A 65-year-old man with arterial hypertension received oral treatment with Ketanserin, a new drug, during a period of five months. He developed marked QT interval prolongation and have several Stokes-Adams attacks. A Holter recording obtained during one of these episodes showed torsade de pointes ventricular tachycardia. The arrhythmias occurred during maximum QT interval prolongation. The correlation between Ketanserin and QT interval prolongation was evaluated by using several Holter studies during administration and withdrawal of the drug. The effect of Ketanserin on the QTc interval was analyzed retrospectively in six patients who had been taking the drug orally. Following a period of four to eight months, the QTc interval was prolonged by the drug (5 to 31%, mean 17%) in five patients. We conclude that torsade de pointes is a potential hazard of long-term treatment with Ketanserin.
SUMMARY Exit block from a parasystolic focus is recognized when automatic discharges fail to become manifest during the excitable phase of the ventricular cycle. In the present study, an apparently complete exit block and a persistently concealed ventricular parasystole (VP) resulted from an exit refractory period (ExRP) longer than the sinus cycle length. Slowing of the heart rate caused the concealed VP to become apparent in the form of ventricular escapes of variable coupling and as an idioventricular rhythm that failed to show initial "warming up." These features reflect the fact that the automatic focus is protected from activity of the sinus impulses, which, however, can induce a prolonged ExRP. Seven cases of concealed VP are discussed. In two, concealment occurred spontaneously during follow-up of a typical VP; in three, it was provoked by conduction-depressing drugs; and in two, ventricular escapes of varying coupling were shown to represent the manifestation of a concealed and previously unrecognized VP. In two cases, isoproterenol caused reappearance of typical VP, probably through a shortening of the ExRP. While isoproterenol may be useful for uncovering a concealed VP, conduction-depressing drugs may be used to provoke or increase exit block. Total extinction of the VP seemed to occur in two patients during follow-up studies.DURING the follow-up of 49 patients with ventricular parasystole (VP), we observed a sustained disappearance of the arrhythmia, occurring spontaneously in two cases and under the effect of antiarrhythmic drugs in three. When the VP was no longer manifest, a slowing of the heart rate caused the arrhythmia to reappear under the form of ventricular escapes (VEs) of variable coupling, or as an idioventricular rhythm in which the first escape interval could be either shorter or longer than the regular interectopic interval (IEI). We also studied two patients in whom VEs of varying coupling were shown to represent the manifestation of a concealed and previously unrecognized VP. These seven cases are reported in order to discuss (1) the existence and diagnostic criteria of concealed VP, (2) the way to uncover this arrhythmia and prove its parasystolic mechanism, (3) the type of exit block underlying this form of VP, and (4) the natural history of VP.Case Reports ( We postulate that the absence of parasystolic beats during antiarrhythmic treatment was due to an apparently complete exit block related to a state of refractoriness generated by each sinus impulse, and that the effective refractory period responsible for such exit block (ExRP) was longer than the spontaneous cycle length. Accordingly, the parasystolic discharges became manifest only when sinoatrial impulses were suppressed by vagal stimulation. If the concealed discharges are traced from the regular IEI ( fig. IB), the timing of the first VE depends not on the preceding sinus beat but on the preceding concealed discharge, and therefore, the VE interval can be either longer or shorter than the IEI. This suggests that the ecto...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.